Quantcast

Latest New England Biolabs Inc. Stories

2014-10-07 12:31:14

Agreement strengthens New England Biolabs' position as a key supplier to the RNA synthesis sector IPSWICH, Mass., Oct. 7, 2014 /PRNewswire/ -- New England Biolabs, Inc. (NEB(®)) has strengthened its position as a key supplier to the fast-growing RNA synthesis market by signing an agreement to supply critical reagents to TriLink BioTechnologies, Inc., a leading manufacturer of mRNA and long RNA for research, diagnostic and therapeutic applications. ?Under the terms of the agreement,...

2014-08-19 12:28:27

First Kit Improves RNA-Seq for FFPE and High-Quality RNA Samples IPSWICH, Mass., Aug. 19, 2014 /PRNewswire/ -- New England Biolabs, Inc. (NEB(®)) today announced that NEB has exclusively in-licensed rights from Genomic Health, Inc. to its technology for the depletion of abundant RNAs, which is instrumental to performing sensitive RNA-seq experiments at a lower cost. http://photos.prnewswire.com/prnvar/20090921/NE79207LOGO-b Ribosomal RNAs (rRNAs) are extremely abundant,...

2014-04-28 16:29:03

IPSWICH, Mass., April 28, 2014 /PRNewswire/ -- New England Biolabs (NEB(®)) announces that it has been awarded a $250,000 grant from the Massachusetts Life Sciences Center (MLSC) to fund a collaboration with Transgene, a French biopharmaceutical company developing innovative immunotherapies for oncology and infectious diseases. http://photos.prnewswire.com/prnvar/20090921/NE79207LOGO-b The collaboration between NEB and Transgene involves an innovative approach to enzymatically...

2014-03-06 12:26:58

Agreement further strengthens New England Biolabs' position as a key supplier to the molecular diagnostics sector IPSWICH, Mass., March 6, 2014 /PRNewswire/ -- New England Biolabs, Inc. (NEB(®)), a world leader in the production and supply of recombinant enzymes and related reagents for the life science industry, has strengthened its position as a key supplier to the fast-growing molecular diagnostics market by signing an agreement to manufacture and supply critical reagents to...

2014-02-11 20:22:28

IPSWICH, Mass., Feb. 11, 2014 /PRNewswire/ -- New England Biolabs, Inc. (NEB(®)) will be presenting its recent innovations for next generation sequencing sample preparation at this year's Advances in Genome Biology and Technology (AGBT) conference from February 12(th) to 15(th) in Marco Island, Florida. These advances, which will include the ability to work with ever more complex and smaller sample inputs, as well as workflow enhancements, will be communicated via a mix of scientific...

2014-02-06 12:28:02

CAMBRIDGE, Mass. and IPSWICH, Mass., Feb. 6, 2014 /PRNewswire/ -- In partnership with the Journal of Visualized Experiments (JoVE), New England Biolabs (NEB(®)) has invited scientists to submit abstracts detailing their unique applications of its Gibson Assembly(®) reagents, for a chance to win a professionally-produced, open-access video publication from JoVE, the most cited, peer-reviewed, video-based journal. (Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b)...

2014-01-28 16:25:37

IPSWICH, Mass., Jan. 28, 2014 /PRNewswire/ -- NEBioCalculator, a new online "conversions and calculations" tool developed by New England Biolabs (NEB(®)), offers bench-side support for molecular biology experimental planning. Boasting improved algorithms and a more intuitive interface, NEBioCalculator supports several commonly-used biomath needs, such as molarity calculation, OD(260) conversion, ligation calculation, and mass/moles conversion for both dsDNA and ssRNA....


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related